Nutrinia, a developer of oral insulin therapies to treat rare gastrointestinal disorders in babies, has…
Halaven (eribulin) manufactured by Japanese drug major Eisai is now available in Russia.
US biotech company Celgene Corp has made two appointments to its EMEA team.
BiotechnologyBoardroomCelgene CorpCelgene Corp.Stefano Portolano
Following evaluation of disappointing clinical results, Danish CNS specialists Lundbeck said late yesterday…
Movement disorder biopharma specialist Auspex Pharmaceuticals announced positive top-line data from its…
A Phase III clinical trial has found that Portola Pharmaceuticals' andexanet alfa reverses the effects…
andexanet alfaBristol-Myers SquibbCardio-vascularEliquisPfizerPharmaceuticalPortola PharmaceuticalsResearchUSA
France-based drug developer Poxel says that imeglimin, a novel compound in development to treat type…
Biopharma company Emergent BioSolutions has acquired the EV-035 series of molecules from Evolva Holding.
Antibiotics and Infectious diseasesBiotechnologyEmergent BioSolutionsEvolvaLicensingResearchUSA
KCR, a Poland-based contract research organization (CRO), has recently acquired the whole portfolio of…
AXIS GroupKCRMergers & AcquisitionsPharmaceuticalResearchUkraine